National Capital Consortium Hematology and Medical Oncology

Topics

• Multiple Myeloma Research and Treatments 51
• Chronic Lymphocytic Leukemia Research 43
• Lymphoma Diagnosis and Treatment 34
• Trauma, Hemostasis, Coagulopathy, Resuscitation 27
• Acute Myeloid Leukemia Research 16
• Physical Activity and Health 13
• CAR-T cell therapy research 12
• Cardiovascular and exercise physiology 9
• Advanced Breast Cancer Therapies 7
• Lung Cancer Treatments and Mutations 6
• Cancer survivorship and care 5
• Cardiac Imaging and Diagnostics 5

Most cited

1. Diagnosis and Management of Multiple Myeloma: A Review.

   JAMA · 2022 · 854 citations · Mary Kwok

2. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.

   The New England journal of medicine · 2023 · 739 citations · Amy Reese

3. Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.

   Blood · 2024 · 124 citations · Rajat Bannerji

4. Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial.

   The Lancet. Haematology · 2022 · 243 citations · Rajat Bannerji

5. Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.

   Blood · 2022 · 218 citations · Rajat Bannerji

6. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.

   The Lancet. Haematology · 2022 · 84 citations · Clifton Mo